These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 237551)

  • 21. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
    Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-hexyl-O-glucosyl sphingosine, an inhibitor of glucosyl ceramide -glucosidase.
    Erickson JS; Radin NS
    J Lipid Res; 1973 Mar; 14(2):133-7. PubMed ID: 4698260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A; Carroll M
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Pentafluoroethylumbelliferyl-beta-D-glucoside as a new fluorogenic substrate for acid beta-D-glucosidase.
    Tsvetkova IV; Karpova EA; Dudukina TV; Voznyi YV
    Clin Chim Acta; 1996 Apr; 248(2):125-33. PubMed ID: 8740577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
    Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
    Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of glucosylsphingosine from Gaucher's spleen.
    Raghavan SS; Mumford RA; Kanfer JN
    J Lipid Res; 1974 Sep; 15(5):484-90. PubMed ID: 4414001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the possible identity of particulate beta-glucosidase and beta-xylosidase of mouse liver.
    Stephens MC; Bernatsky A; Legler G; Kanfer JN
    Biochim Biophys Acta; 1979 Nov; 571(1):70-8. PubMed ID: 40616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M
    J Inherit Metab Dis; 1985; 8(1):33-7. PubMed ID: 3921758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
    Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
    Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoenzymes of membrane-bound beta-glucosidase of human spleen.
    Yaqoob M; Carroll M
    Biochem J; 1980 Feb; 185(2):541-3. PubMed ID: 6772153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
    Ben-Yoseph Y; Nadler HL
    J Clin Pathol; 1978 Nov; 31(11):1091-3. PubMed ID: 105017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein).
    Berent SL; Radin NS
    Biochim Biophys Acta; 1981 Jun; 664(3):572-82. PubMed ID: 6268176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble and membranous neutral beta-glucosidases.
    Ben-Yoseph Y; Nadler HL
    Prog Clin Biol Res; 1982; 95():465-80. PubMed ID: 6812082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
    Broadhead DM; Butterworth J
    Clin Chim Acta; 1977 Feb; 75(1):155-61. PubMed ID: 14796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
    Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
    Shafit-Zagardo B; Devine EA; Desnick RJ
    Biochim Biophys Acta; 1980 Aug; 614(2):459-65. PubMed ID: 6773581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple forms of acid phosphatase activity in Gaucher's disease.
    Chambers JP; Peters SP; Glew RH; Lee RE; McCafferty LR; Mercer DW; Wenger DA
    Metabolism; 1978 Jul; 27(7):801-14. PubMed ID: 26832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB; Glew RH
    Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
    Wenger DA; Clark C; Sattler M; Wharton C
    Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.